Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts. Separating true intrinsic value from speculation isn’t easy, especially during bull markets. That’s where StockStory comes in - to help you find high-quality companies that will stand the test of time. That said, here are three high-flying stocks where the price is not right and some other investments you should look into instead. Live Nation (LYV) Forward P/E Ratio: 60.6x Owner of Ticketmaster and operator of music festival EDC, Live Nation (NYSE:LYV) is a company specializing in live event promotion, venue management, and ticketing services for concerts and shows. Why Are We Hesitant About LYV? Sluggish trends in its events suggest customers aren’t adopting its solutions as quickly as the company hoped Responsiveness to unforeseen market trends is restricted due to its substandard operating profitability Free cash flow margin is forecasted to shrink by 1.9 percentage points in the coming year, suggesting the company will consume more capital to keep up with its competitors Live Nation is trading at $138.98 per share, or 60.6x forward P/E. Read our free research report to see why you should think twice about including LYV in your portfolio, it’s free. SoundHound AI (SOUN) Forward P/S Ratio: 31.2x Founded in 2005, SoundHound AI (NASDAQ:SOUN) develops independent voice artificial intelligence solutions that enable businesses across various industries to offer customized conversational experiences to consumers. Why Are We Cautious About SOUN? Bad unit economics and steep infrastructure costs are reflected in its gross margin of 44.1%, one of the worst among software companies Operating margin declined by 39 percentage points over the last year as it scaled Cash-burning history makes us doubt the long-term viability of its business model At $11.76 per share, SoundHound AI trades at 31.2x forward price-to-sales. If you’re considering SOUN for your portfolio, see our FREE research report to learn more. LifeStance Health Group (LFST) Forward P/E Ratio: 75.7x With over 6,600 licensed mental health professionals treating more than 880,000 patients annually, LifeStance Health (NASDAQ:LFST) provides outpatient mental health services through a network of clinicians offering psychiatric evaluations, psychological testing, and therapy across 33 states. Why Does LFST Give Us Pause? Modest revenue base of $1.28 billion gives it less fixed cost leverage and fewer distribution channels than larger companies Cash burn makes us question whether it can achieve sustainable long-term growth Push for growth has led to negative returns on capital, signaling value destruction Story Continues LifeStance Health Group’s stock price of $5.74 implies a valuation ratio of 75.7x forward P/E. Check out our free in-depth research report to learn more about why LFST doesn’t pass our bar. Stocks We Like More The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. View Comments
3 High-Flying Stocks Skating on Thin Ice
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...